CIK 0001600620
- Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981231763
- Phone
- +1 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $735,889
- in 3 filings
Net −$735,889. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-12 | MacKay-Dunn R. Hector Director | Purchase | +1,600 | $11.28 | $18K | 6,000 |
| 2021-05-11 | MacKay-Dunn R. Hector Director | Purchase | +500 | $11.17 | $6K | 2,000 |
| 2021-05-11 | MacKay-Dunn R. Hector Director | Purchase | +1,000 | $11.14 | $11K | 3,000 |
| 2021-05-11 | Donley Matthew Maxwell Ex VP, Intern'l Operations | Purchase | +9,900 | $10.07 | $100K | 9,900 |
| 2021-05-11 | Greenleaf Peter Chief Executive Officer | Purchase | +2,133 | $10.15 | $22K | 10,461 |
| 2021-05-11 | Greenleaf Peter Chief Executive Officer | Purchase | +2,992 | $11.11 | $33K | 13,453 |
| 2021-05-11 | Martin Michael Robert Chief Business Officer | Option exercise | +20,000 | $3.02 | $60K | 221,861 |
| 2021-05-11 | Martin Michael Robert Chief Business Officer | Option exercise · Option Grant (right to buy) | −20,000 | 0 | ||
| 2021-05-11 | Leversage Jill Director | Purchase | +2,500 | $10.96 | $27K | 3,700 |
| 2021-05-11 | Huizinga Robert Bindert Ex Vice President of Research | Option exercise | +40,000 | $3.02 | $121K | 143,592 |
| 2021-05-11 | Huizinga Robert Bindert Ex Vice President of Research | Option exercise · Stock Option (right to buy) | −40,000 | 0 | ||
| 2021-05-11 | Miller Joseph M Chief Financial Officer | Purchase | +1,000 | $9.74 | $10K | 1,000 |
| 2021-03-12 | Solomons Neil Chief Medical Officer | Option exercise | +40,000 | $3.02 | $121K | 227,299 |
| 2021-03-12 | Solomons Neil Chief Medical Officer | Sale | −40,000 | $13.49 | $540K | 187,299 |
| 2021-03-12 | Solomons Neil Chief Medical Officer | Option exercise · Stock Option (right to buy) | −40,000 | 0 | ||
| 2021-03-05 | MILNE GEORGE M JR Director | Purchase | +5,000 | $13.00 | $65K | 45,000 |
| 2021-01-29 | Leversage Jill Director | Purchase | +400 | $16.03 | $6K | 400 |
| 2021-01-29 | Leversage Jill Director | Purchase | +1,200 | $16.03 | $19K | 1,200 |
| 2021-01-29 | Hayden Michael R Director | Option exercise | +50,000 | $5.44 | $272K | 50,000 |
| 2021-01-29 | Hayden Michael R Director | Option exercise | +30,000 | $6.06 | $182K | 80,000 |
Page 17 of 18 · 345 trades